Literature DB >> 4621966

Immunoglobulin M: fixation of human complement by the Fc fragment.

A G Plaut, S Cohen, T B Tomasi.   

Abstract

The Fc fragment [(Fc)(5)micro with a molecular weight of 342,000] of human immunoglobulin M from patients with Waldenström's macroglobulinemia has a complement fixing ability approximately 19 times greater on a molar basis than that of the parent immunoglobulin M. This fragment, which occurs naturally as a pentamer fixes human but not guinea pig complement, and this activity remains unchanged even after the fragment is reduced to the monomeric form.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4621966     DOI: 10.1126/science.176.4030.55

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  6 in total

1.  A comparative analysis of the C1-binding ability of fragments derived from complement-fixing and noncomplement-fixing IgM proteins.

Authors:  M M Hurst; J E Volanakis; R M Stroud; J C Bennett
Journal:  J Clin Invest       Date:  1976-07       Impact factor: 14.808

2.  Effector activating determinants on IgG. I. The distribution and factors influencing the display of complement, neutrophil and cytotoxic B-cell determinants on human IgG sub-classes.

Authors:  I C MacLennan; A Howard; F M Gotch; P G Quie
Journal:  Immunology       Date:  1973-09       Impact factor: 7.397

3.  Antigen binding and complement fixing activity of IgM molecules reassociated in the presence and absence of J chains.

Authors:  E Kownatzki; M Drescher
Journal:  Clin Exp Immunol       Date:  1973-12       Impact factor: 4.330

4.  Complement fixation by rheumatoid factor.

Authors:  K Tanimoto; N R Cooper; J S Johnson; J H Vaughan
Journal:  J Clin Invest       Date:  1975-03       Impact factor: 14.808

Review 5.  The first component of human complement (C1): activation and control.

Authors:  R J Ziccardi
Journal:  Springer Semin Immunopathol       Date:  1983

6.  Receptors for IgM on human lymphocytes. III. Specificity of receptors.

Authors:  M W Fanger; P M Lydyard
Journal:  Clin Exp Immunol       Date:  1979-09       Impact factor: 4.330

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.